← Leaderboards
Tibor Szentendrei
Kai Research, Inc
$3,272,145
Attributed
$3,272,145
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $664.7K · FY2014–22$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$3,272,145 · 2
By mechanism
N01$2,685,620 · 2
N02$586,525 · 1
Top collaborators
No co-investigators on record.
Most similar at Kai Research, Inc
Same institution · by research overlap
- Selma C. Kunitz$6,721,504
- Selma Kunitz$3,824,598
- Rene C. Kozloff$1,693,496
- Kathy Dimeo$8,614,667
- Swlma Kunitz$455,398
Others in their field
Top investigators on “Operation”
- Everette D Joseph · Howard University$1,408,485,607
- David Heimbrook · Leidos Biomedical Research, Inc.$1,034,764,065
- Leonard Freedman · Leidos Biomedical Research, Inc.$840,220,658
- Lawrence Corey · Fred Hutchinson Cancer Center$745,549,177
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$629,268,361
Research focus
OperationFundingClinical TrialsProceduresParticipantTrainingContractorContractsDatabasesData QualityData Quality/IntegrityElderlyEnsureGuidelinesHuman SubjectAccelerometerMaintenanceOnline SystemsPersonal SatisfactionPrincipal InvestigatorProgramsQuality AssuranceReportingResearch Personnel
Grant awards (6)
THE PURPOSE IS TO CONTINUE OPERATION OF THE NIA CTOSC IN ORDER TO PROVIDE SUPPORT FOR THE MANAGEMENT, TRACKING, AND OVERSIGHT OF CLINICAL TRIALS FUNDED BY THE NIA.$664,669
N01 · FY2022 · DA · contact PI
THE PURPOSE IS TO CONTINUE OPERATION OF THE NIA CTOSC IN ORDER TO PROVIDE SUPPORT FOR THE MANAGEMENT, TRACKING, AND OVERSIGHT OF CLINICAL TRIALS FUNDED BY THE NIA.$636,284
N01 · FY2021 · DA · contact PI
THE PURPOSE IS TO CONTINUE OPERATION OF THE NIA CTOSC IN ORDER TO PROVIDE SUPPORT FOR THE MANAGEMENT, TRACKING, AND OVERSIGHT OF CLINICAL TRIALS FUNDED BY THE NIA.$612,784
N01 · FY2019 · DA · contact PI
'IGF::OT::IGF'$160,968
N01 · FY2017 · DA · contact PI
NIA CLINICAL TRIALS OPERATIONS SUPPORT CENTER$610,915
N01 · FY2016 · DA · contact PI
Clinical Trials Operations Support Center (CTOSC)$586,525
N02 · FY2014 · DA · contact PI